Literature DB >> 9832956

The effects of anandamide on memory consolidation in mice involve both D1 and D2 dopamine receptors.

C Castellano1, S Cabib, A Palmisano, V Di Marzo, S Puglisi-Allegra.   

Abstract

Post-training administration of anandamide (1.5, 3, 6 mg/kg) dose-dependently impairs the retention of an inhibitory avoidance response in mice. The effects on retention performance induced by the drug appear to be due to an effect on memory consolidation, as they were observed when drugs were given at short, but not long, periods of time after training, i.e. when the memory trace was susceptible to modulation. Pretreatment with either selective D1 or D2 dopamine (DA) receptor agonists, SKF 38393 and quinpirole, at doses that were ineffective when given alone (5 and 0.25 mg/kg, respectively), antagonized the effects of anandamide on memory consolidation, suggesting that D1 and D2 receptors are similarly involved in the effects of anandamide on memory consolidation. These results are discussed in terms of a possible inverse relationship between the modulation of memory processes by endogenous cannabinoid and DA systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9832956     DOI: 10.1097/00008877-199712000-00005

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  8 in total

1.  Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus.

Authors:  Anushka V Goonawardena; John Sesay; Cheryl Ann Sexton; Gernot Riedel; Robert E Hampson
Journal:  Neuropharmacology       Date:  2011-07-13       Impact factor: 5.250

2.  Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors.

Authors:  A Bilkei-Gorzo; I Racz; O Valverde; M Otto; K Michel; M Sastre; M Sarstre; A Zimmer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-12       Impact factor: 11.205

3.  Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors.

Authors:  Carmen Mazzola; Julie Medalie; Maria Scherma; Leigh V Panlilio; Marcello Solinas; Gianluigi Tanda; Filippo Drago; Jean Lud Cadet; Steven R Goldberg; Sevil Yasar
Journal:  Learn Mem       Date:  2009-04-29       Impact factor: 2.460

4.  Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.

Authors:  Maria Scherma; Leigh V Panlilio; Paola Fadda; Liana Fattore; Islam Gamaleddin; Bernard Le Foll; Zuzana Justinová; Eva Mikics; Jozsef Haller; Julie Medalie; Jessica Stroik; Chanel Barnes; Sevil Yasar; Gianluigi Tanda; Daniele Piomelli; Walter Fratta; Steven R Goldberg
Journal:  J Pharmacol Exp Ther       Date:  2008-08-25       Impact factor: 4.030

5.  Sulfonyl fluoride inhibitors of fatty acid amide hydrolase.

Authors:  Shakiru O Alapafuja; Spyros P Nikas; Indu T Bharathan; Vidyanand G Shukla; Mahmoud L Nasr; Anna L Bowman; Nikolai Zvonok; Jing Li; Xiaomeng Shi; John R Engen; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2012-11-02       Impact factor: 7.446

6.  Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice.

Authors:  Balapal S Basavarajappa; Nagaraja N Nagre; Shan Xie; Shivakumar Subbanna
Journal:  Hippocampus       Date:  2014-03-28       Impact factor: 3.899

7.  Effects of endocannabinoid system modulation on cognitive and emotional behavior.

Authors:  Claudio Zanettini; Leigh V Panlilio; Mano Alicki; Steven R Goldberg; József Haller; Sevil Yasar
Journal:  Front Behav Neurosci       Date:  2011-09-13       Impact factor: 3.558

8.  Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain.

Authors:  Shuiliang Yu; Liraz Levi; Gemma Casadesus; George Kunos; Noa Noy
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.486

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.